Bullish Options Activity in Teva Pharma (TEVA) Continues -Susquehanna

Susquehanna options strategist Alison Edwards notes a continuation of bullish options activity in Teva Pharma (NYSE: TEVA), as an opening investor bought 18k Jan 15 Calls for $1.39, creating ~1 million shares to buy, following yesterday’s bullish Nov24 13 put selling and Jan 17.5 call buying.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Aurinia settles patent dispute with Teva over generic voclosporin
• Palo Alto Networks (PANW) call put ratio 1 call to 1.2 puts amid price movement